Commonwealth Transitions Competitors

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling almost 12 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets (September 30, 2025). For its customers, ZEISS develops, produces, and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses, and binoculars. With a portfolio aligned with future growth areas like digitalization, healthcare, and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 15 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future. With over 46,600 employees, ZEISS is active globally in around 50 countries with more than 60 sales and service locations, around 40 research and development facilities, and 30 production facilities worldwide. Learn more about ZEISS: www.zeiss.com/about Data privacy: www.zeiss.com/data-protection Imprint: www.zeiss.com/publisher This is ZEISS's official LinkedIn account. It follows the ZEISS Netiquette: www.zeiss.com/netiquette

See What's Possible! VSP Global is a group of progressive companies that offers innovative and personalized eye care, optical, and business solutions to help people see. VSP Global includes VSP Vision Care, Marchon Eyewear, Eyefinity, VSP Optics Group, VSP Retail, and our global charity platform, Eyes of Hope. VSP Vision Care The largest not-for-profit vision benefits and services company in the world with 32,000 doctors and more than 75 million members worldwide. Marchon Eyewear One of the world's largest designer manufacturers and distributors of both sun and optical fashion. Marchon includes Altair Eyewear, another frame designer, as well as Eye Designs, a leader in the design of custom interiors and merchandising systems for the optical industry. Eyefinity The premier practice management software and technology company in the United States, offering OfficeMate/ExamWRITER electronic health records and multilocation software. VSP Optics Group VSP Optics Group provides ophthalmic technology, lens products, and lab services that strengthen the patient experience and promote practice growth. VSP Omni-Channel Solutions VSP Retail exists to deliver a superior customer experience through a variety of retail channels that meet the diverse needs of our customers. Eyes of Hope Our global charity platform designed to provide access to eye care and eyewear. We support local communities around the globe through programs that bring disaster relief, education, and eye care to where they're needed most. To date, we've invested more than $170 million in free eye care and eyewear for more than 935,000 adults and children in need.

The world's leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, Eyezen™, Xperio®, Foster Grant® and Bolon™. It also develops and markets equipment, instruments and services for eyecare professionals. Essilor employs close to 69,000 people worldwide. The Group has 32 plants, 490 prescription laboratories and edging facilities, 14 distribution centers, as well as 5 research and development centers around the world. For more information, please visit https://www.essilor.com.